TCI Wealth Advisors’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,608
| Closed | -$386K | – | 2693 |
|
|
2022
Q4 | $386K | Buy |
11,608
+11,380
| +4,991% | +$367K | 0.05% | 120 |
|
|
2022
Q3 | $7K | Hold |
228
| – | – | ﹤0.01% | 1305 |
|
|
2022
Q2 | $7K | Hold |
228
| – | – | ﹤0.01% | 1308 |
|
|
2022
Q1 | $6K | Hold |
228
| – | – | ﹤0.01% | 1490 |
|
|
2021
Q4 | $5K | Buy |
228
+46
| +25% | +$882 | ﹤0.01% | 1757 |
|
|
2021
Q3 | $4K | Buy |
182
+61
| +50% | +$1.22K | ﹤0.01% | 1866 |
|
|
2021
Q2 | $3K | Buy |
121
+33
| +38% | +$700 | ﹤0.01% | 1907 |
|
|
2021
Q1 | $2K | Sell |
88
-12
| -12% | -$285 | ﹤0.01% | 1977 |
|
|
2020
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 1306 |
|
|
2020
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 1223 |
|
|
2020
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 1166 |
|
|
2020
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 1400 |
|
|
2019
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 1484 |
|
|
2019
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 1436 |
|
|
2019
Q2 | $1K | Buy |
+100
| New | +$1.21K | ﹤0.01% | 1361 |
|
|
2018
Q2 | – | Sell |
-177
| Closed | -$3K | – | 1637 |
|
|
2018
Q1 | $3K | Buy |
+177
| New | +$2.62K | ﹤0.01% | 898 |
|
|
2016
Q4 | – | Sell |
-65
| Closed | -$1K | – | 1476 |
|
|
2016
Q3 | $1K | Hold |
65
| – | – | ﹤0.01% | 1260 |
|
|
2016
Q2 | $1K | Hold |
65
| – | – | ﹤0.01% | 1194 |
|
|
2016
Q1 | $1K | Buy |
+65
| New | +$1.28K | ﹤0.01% | 1198 |
|
Other funds holding VIVO
TCI Wealth Advisors's VIVO Position: Q1 2023 in Review
TCI Wealth Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 11,608 shares — an estimated $386K sold.
TCI Wealth Advisors first reported a position in VIVO in Q1 2016 and held it in 19 quarters. The position peaked at $386K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- TCI Wealth Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 11,608 Meridian Bioscience Inc shares in Q1 2023, an estimated $386K.
- TCI Wealth Advisors first reported a position in Meridian Bioscience Inc in Q1 2016 and held it in 19 quarters.
- TCI Wealth Advisors's Meridian Bioscience Inc position peaked at $386K in Q4 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.